June 2015
In this Supplement
Surgical Bypass Summit
Individualizing Surgical Bypass: Changing the Paradigm
Sponsored by Gore & AssociatesSESSION 1
Current state of bypass for lower extremity revascularization: What are the real results?
Role of Surgical Bypass in a Limb Preservation Program
By Richard F. Neville, MD
Alternative Conduits
By Efthymios D. Avgerinos, MD, PhD
Vein Versus Heparin-Bonded ePTFE
By Prof. Raffaele Pulli; Walter Dorigo, MD; and Prof. Carlo Pratesi, on behalf of the Italian Registry Group*
Is Vein Still the First Choice When a Leg Bypass Is Needed?
By Joseph L. Mills, Sr, MD
SESSION 2
Bypass in the world of "endovascular first": How does it fit in today's treatment algorithm?
There Are Negative Consequences That Persist After Failed Endovascular Treatment of CLI
By Ross Milner, MD
Gender Differences in PAD Treatment
By Venita Chandra, MD
The BEST-CLI Trial: Will It Conclusively Direct Treatment?
By Michael S. Conte, MD
SESSION 3
What are the advantages of a prosthetic conduit?
Should Complications and Modes of Failure Affect Our Choice?
By R. Clement Darling, III, MD
CBAS® Heparin Surface
By Russell H. Samson, MD, FACS, RVT
When to Use Graft Versus Multisegment Spliced Vein
By Prof. Thomas Schmitz-Rixen
SESSION 4
Future improvements in graft performance
The Impact of Drug Therapy on Surgical Bypass
By Russell H. Samson, MD, FACS, RVT
Sequential Bypass
By Jean Bismuth, MD
SESSION 5
How will financial considerations affect future decisions?